{"id":83818,"date":"2026-05-08T13:11:30","date_gmt":"2026-05-08T07:41:30","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=83818"},"modified":"2026-05-08T13:11:32","modified_gmt":"2026-05-08T07:41:32","slug":"thyrocare-technologies-q4-fy26","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/thyrocare-technologies-q4-fy26\/","title":{"rendered":"Thyrocare Technologies Q4 FY26 Results Diagnostic Services Annual Performance"},"content":{"rendered":"<div class=\"meta-block\">\u00a0<\/div>\n<p><a href=\"https:\/\/univest.in\/user\/stocks\/thyrocare\/thyrocare-technologies-ltd-share-price-today\">Thyrocare Technologies<\/a> Q4 results for FY26 were announced by the board on 7 May 2026. The Thyrocare Technologies Q4 business operates as a centralized diagnostic laboratory chain providing preventive health check packages, pathology testing, and radiology services across India through its franchise and collection center network.<\/p>\n<p>Investors tracking Thyrocare Technologies Q4 results FY26 should note that through Q3 FY26, the company reported consolidated revenue of Rs 195.53 crore and PAT of Rs 34.07 crore. FY25 full-year consolidated revenue was Rs 687.30 crore with PAT excluding exceptional items at Rs 101.20 crore, providing the baseline for FY26 performance assessment.<\/p>\n<p><a href=\"https:\/\/univest.in\/user\/log-in\"><strong>Get Free Stock Recommendations on Univest<\/strong><\/a><\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/thyrocare-technologies-q4-fy26\/#Thyrocare_Technologies_Q4_FY26_Results_at_a_Glance\" title=\"Thyrocare Technologies Q4 FY26 Results at a Glance\">Thyrocare Technologies Q4 FY26 Results at a Glance<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/thyrocare-technologies-q4-fy26\/#Key_Highlights_from_Thyrocare_Technologies_Q4_FY26\" title=\"Key Highlights from Thyrocare Technologies Q4 FY26\">Key Highlights from Thyrocare Technologies Q4 FY26<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/thyrocare-technologies-q4-fy26\/#Centralized_Lab_Model_and_Preventive_Health\" title=\"Centralized Lab Model and Preventive Health\">Centralized Lab Model and Preventive Health<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/thyrocare-technologies-q4-fy26\/#Diagnostic_Sector_Growth_Drivers\" title=\"Diagnostic Sector Growth Drivers\">Diagnostic Sector Growth Drivers<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/thyrocare-technologies-q4-fy26\/#Competition_and_PharmEasy_Integration\" title=\"Competition and PharmEasy Integration\">Competition and PharmEasy Integration<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/thyrocare-technologies-q4-fy26\/#Risks_to_Monitor\" title=\"Risks to Monitor\">Risks to Monitor<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/thyrocare-technologies-q4-fy26\/#Conclusion\" title=\"Conclusion\">Conclusion<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/thyrocare-technologies-q4-fy26\/#Frequently_Asked_Questions\" title=\"Frequently Asked Questions\">Frequently Asked Questions<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/thyrocare-technologies-q4-fy26\/#What_does_Thyrocare_Technologies_do\" title=\"What does Thyrocare Technologies do?\">What does Thyrocare Technologies do?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/thyrocare-technologies-q4-fy26\/#When_were_Thyrocare_Technologies_Q4_FY26_results_announced\" title=\"When were Thyrocare Technologies Q4 FY26 results announced?\">When were Thyrocare Technologies Q4 FY26 results announced?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/thyrocare-technologies-q4-fy26\/#What_was_Thyrocare_Technologies_Q3_FY26_performance\" title=\"What was Thyrocare Technologies Q3 FY26 performance?\">What was Thyrocare Technologies Q3 FY26 performance?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/thyrocare-technologies-q4-fy26\/#Who_owns_Thyrocare_Technologies\" title=\"Who owns Thyrocare Technologies?\">Who owns Thyrocare Technologies?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/thyrocare-technologies-q4-fy26\/#What_is_Thyrocare_Technologies_Q4_competitive_position\" title=\"What is Thyrocare Technologies Q4 competitive position?\">What is Thyrocare Technologies Q4 competitive position?<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/thyrocare-technologies-q4-fy26\/#Recent_Article\" title=\"Recent Article\">Recent Article<\/a><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Thyrocare_Technologies_Q4_FY26_Results_at_a_Glance\"><\/span><strong>Thyrocare Technologies Q4 FY26 Results at a Glance<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table>\n<tbody>\n<tr>\n<th>Metric<\/th>\n<th>Q4 FY26 \/ FY26<\/th>\n<th>Change<\/th>\n<\/tr>\n<tr>\n<td>Q3 FY26 Revenue<\/td>\n<td>Rs 195.53 crore<\/td>\n<td>Quarterly standalone<\/td>\n<\/tr>\n<tr>\n<td>Q3 FY26 PAT<\/td>\n<td>Rs 34.07 crore<\/td>\n<td>After exceptional items<\/td>\n<\/tr>\n<tr>\n<td>FY25 Revenue<\/td>\n<td>Rs 687.30 crore<\/td>\n<td>Full year baseline<\/td>\n<\/tr>\n<tr>\n<td>FY25 PAT (ex-exceptional)<\/td>\n<td>Rs 101.20 crore<\/td>\n<td>FY25 full year<\/td>\n<\/tr>\n<tr>\n<td>Board Meeting<\/td>\n<td>7 May 2026<\/td>\n<td>Q4 FY26 results approved<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Track live financials and analyst ratings on the <a href=\"https:\/\/univest.in\/screeners\"><strong>Univest Screener<\/strong><\/a>.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Key_Highlights_from_Thyrocare_Technologies_Q4_FY26\"><\/span><strong>Key Highlights from Thyrocare Technologies Q4 FY26<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Centralized_Lab_Model_and_Preventive_Health\"><\/span><strong>Centralized Lab Model and Preventive Health<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>The Thyrocare Technologies Q4 business model centers on centralized, automated laboratory processing which enables low-cost testing across a wide panel of preventive health packages. The Thyrocare Technologies Q4 franchise network of over 1,800 collection centers ensures broad geographic reach, with samples processed at central labs in Mumbai and Navi Mumbai for turnaround time efficiency.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Diagnostic_Sector_Growth_Drivers\"><\/span><strong>Diagnostic Sector Growth Drivers<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>The Thyrocare Technologies Q4 results are shaped by the growing awareness of preventive healthcare in India, increasing insurance penetration driving health check demand, and the organized diagnostic sector&#8217;s expansion beyond metros into tier-2 and tier-3 cities. The Thyrocare Technologies Q4 affordable pricing model positions it well to capture this expanding preventive diagnostics market.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Competition_and_PharmEasy_Integration\"><\/span><strong>Competition and PharmEasy Integration<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>The Thyrocare Technologies Q4 results are influenced by its relationship with PharmEasy, which acquired a controlling stake in the company. The Thyrocare Technologies Q4 management and strategic direction continue to be shaped by this ownership structure and its implications for digital health integration and cross-selling diagnostic services through the PharmEasy platform.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Risks_to_Monitor\"><\/span><strong>Risks to Monitor<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<ul>\n<li><strong>Competition from Vijaya, Dr. Lal, Metropolis:<\/strong> Established diagnostic chains and new entrants compete with Thyrocare Technologies Q4 on price, test range, and turnaround time.<\/li>\n<li><strong>PharmEasy financial health:<\/strong> The financial condition of the parent PharmEasy entity could affect Thyrocare Technologies Q4 strategic decisions and capital allocation.<\/li>\n<li><strong>Pricing pressure:<\/strong> Commoditization of routine diagnostic tests reduces Thyrocare Technologies Q4 realisations in the core preventive health package business.<\/li>\n<li><strong>Regulatory compliance:<\/strong> NABL accreditation requirements and quality standards compliance are critical for maintaining Thyrocare Technologies Q4 test validity and customer trust.<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"Conclusion\"><\/span><strong>Conclusion<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The Thyrocare Technologies Q4 results FY26 reflect a diagnostic company leveraging India&#8217;s growing preventive healthcare awareness through its centralized, low-cost laboratory model. The Thyrocare Technologies Q4 franchise network and affordable pricing create a broad market reach.<\/p>\n<p>For FY27, the most important variable for Thyrocare Technologies Q4 investors is whether the company can accelerate revenue growth through digital health platform integration, new preventive package offerings, and deeper penetration of tier-2 and tier-3 city markets.<\/p>\n<p>Download the <a href=\"http:\/\/apps.apple.com\/in\/app\/univest-stocks-investment\/id6443753518\" rel=\"nofollow noopener\" target=\"_blank\"><strong>Univest iOS App<\/strong><\/a> or <a href=\"http:\/\/play.google.com\/store\/apps\/details?id=com.univest.capp&amp;hl=en_IN\" rel=\"nofollow noopener\" target=\"_blank\"><strong>Univest Android App<\/strong><\/a> for live Q4 results tracking and expert research.<\/p>\n<p><strong>Disclaimer:<\/strong> This article is for educational and informational purposes only and does not constitute investment advice. Univest analysts are SEBI-registered research analysts (SEBI RA: INH000012449). Investments in the securities market are subject to market risk. Consult a SEBI-registered financial advisor before making any investment decisions.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions\"><\/span><strong>Frequently Asked Questions<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"What_does_Thyrocare_Technologies_do\"><\/span><strong>What does Thyrocare Technologies do?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Thyrocare Technologies Q4 provides preventive health diagnostics through centralized automated labs and a franchise collection center network across India, offering thyroid tests, health packages, and pathology services at affordable prices.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"When_were_Thyrocare_Technologies_Q4_FY26_results_announced\"><\/span><strong>When were Thyrocare Technologies Q4 FY26 results announced?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Thyrocare Technologies Q4 FY26 results were announced by the board on May 7, 2026. Detailed financial metrics are available in BSE and NSE exchange filings.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_was_Thyrocare_Technologies_Q3_FY26_performance\"><\/span><strong>What was Thyrocare Technologies Q3 FY26 performance?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Thyrocare Technologies reported Q3 FY26 consolidated revenue of Rs 195.53 crore and PAT of Rs 34.07 crore. Full year FY25 PAT excluding exceptional items was Rs 101.20 crore.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Who_owns_Thyrocare_Technologies\"><\/span><strong>Who owns Thyrocare Technologies?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Thyrocare Technologies Q4 is majority owned by PharmEasy, which acquired a controlling stake. The company operates as a listed subsidiary with its centralized diagnostic laboratory business.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_Thyrocare_Technologies_Q4_competitive_position\"><\/span><strong>What is Thyrocare Technologies Q4 competitive position?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Thyrocare Technologies Q4 competes with Dr. Lal PathLabs, Vijaya Diagnostic Centre, Metropolis Healthcare, and others in India&#8217;s organized diagnostic sector, differentiated by its centralized processing model and affordable preventive health packages.<\/p><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Recent_Article\"><\/span><strong>Recent Article<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><p><a href=\"https:\/\/univest.in\/blogs\/why-is-ahlucont-share-price-falling-key-reasons-2026\">Why Is Ahluwalia Contracts Share Price Falling Key Reasons 2026<\/a><\/p><p><a href=\"https:\/\/univest.in\/blogs\/why-is-ahlucont-share-price-falling-key-reasons-2026\">Why Is Ahluwalia Contracts Share Price Falling Key Reasons 2026<\/a><\/p><p><a href=\"https:\/\/univest.in\/blogs\/why-is-nuvoco-share-price-falling-key-reasons-2026\">Why Is Nuvoco Vistas Corporation Share Price Falling Key Reasons 2026<\/a><\/p><p><a href=\"https:\/\/univest.in\/blogs\/why-is-capacite-share-price-falling-key-reasons-2026\">Why Is Capacite Infraprojects Share Price Falling Key Reasons 2026<\/a><\/p><p><a href=\"https:\/\/univest.in\/blogs\/why-is-psp-projects-share-price-falling-key-reasons-2026\">Why Is PSP Projects Share Price Falling Key Reasons 2026<\/a><\/p>","protected":false},"excerpt":{"rendered":"<p>Thyrocare Technologies Q4 FY26 results announced May 7. Centralized diagnostic lab chain. Q3 FY26 PAT Rs 34.07 crore. Preventive health focus and franchise network drive growth.<\/p>\n","protected":false},"author":26,"featured_media":83892,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[842],"tags":[],"class_list":["post-83818","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"metadata":{"rank_math_internal_links_processed":["1"],"_edit_lock":["1778226104:26"],"_last_editor_used_jetpack":["block-editor"],"rank_math_primary_category":["842"],"rank_math_seo_score":["76"],"rank_math_focus_keyword":["Thyrocare Technologies Q4"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"],"rank_math_title":["Thyrocare Technologies Q4 FY26 Results Diagnostics Revenue Annual Review"],"rank_math_description":["Thyrocare Technologies Q4 FY26 results announced May 7. Diagnostic healthcare company. Q3 FY26 PAT Rs 34.07 crore. FY25 PAT Rs 101.20 crore. Preventive diagnostics focus."],"_thumbnail_id":["83892"],"_edit_last":["26"],"_ez-toc-disabled":[""],"_ez-toc-insert":[""],"_ez-toc-header-label":[""],"_ez-toc-alignment":["none"],"_ez-toc-heading-levels":["a:0:{}"],"_ez-toc-alttext":[""],"_ez-toc-visibility_hide_by_default":[""],"_ez-toc-hide_counter":[""],"_ez-toc-exclude":[""],"_ez-toc-position-specific":["before"],"stm_select_gm_zoom":[""],"stm_agenda":[""],"stm_host":[""],"stm_select_approved_denied":[""],"stm_multiselect_approved":[""],"stm_multiselect_denied":[""],"stm_date":[""],"stm_time":[""],"stm_timezone":[""],"stm_duration":[""],"stm_password":[""],"stm_waiting_room":[""],"stm_join_before_host":[""],"stm_host_join_start":[""],"stm_start_after_participants":[""],"stm_mute_participants":[""],"stm_enforce_login":[""],"stm_alternative_hosts":[""],"top_bar_custom_style":[""],"top_bar_bg":[""],"wc_top_bar_cart_custom_style":[""],"wc_top_bar_cart_color":[""],"wc_top_bar_cart_icon_color_hover":[""],"wc_top_bar_cart_counter_color":[""],"wc_top_bar_cart_counter_color_hover":[""],"wc_top_bar_cart_counter_bg":[""],"wc_top_bar_cart_counter_bg_hover":[""],"top_bar_wpml_switcher_custom_style":[""],"wpml_switcher_color":[""],"top_bar_wpml_switcher_bg":[""],"top_bar_wpml_switcher_bg_hover":[""],"top_bar_wpml_switcher_color_hover":[""],"top_bar_socials_custom_style":[""],"top_bar_socials_color":[""],"top_bar_socials_color_hover":[""],"top_bar_search_custom_style":[""],"top_bar_search_color":[""],"top_bar_search_icon_color_hover":[""],"top_bar_contact_info_style":[""],"top_bar_contact_info_color":[""],"top_bar_contact_info_link_color":[""],"top_bar_contact_info_link_color_hover":[""],"top_bar_contact_info_select_bg":[""],"top_bar_contact_info_select_color":[""],"top_bar_contact_info_select_drop_bg":[""],"top_bar_contact_info_select_items_bg":[""],"top_bar_contact_info_select_items_color":[""],"top_bar_contact_info_select_items_hover":[""],"header_inverse":["default"],"enable_header_transparent":["off"],"header_nav_custom_style":[""],"header_bg":[""],"header_shadow":[""],"wc_cart_custom_style":[""],"wc_cart_icon_color":[""],"wc_cart_icon_color_hover":[""],"wc_cart_counter_color":[""],"wc_cart_counter_color_hover":[""],"wc_cart_counter_bg":[""],"wc_cart_counter_bg_hover":[""],"header_wpml_switcher_custom_style":[""],"header_wpml_switcher_color":[""],"header_wpml_switcher_color_hover":[""],"header_wpml_switcher_bg":[""],"header_wpml_switcher_bg_hover":[""],"header_socials_custom_style":[""],"header_socials_color":[""],"header_socials_color_hover":[""],"header_search_custom_style":[""],"header_search_icon_color":[""],"header_search_icon_color_hover":[""],"header_contact_info_style":[""],"header_contact_info_color":[""],"header_contact_info_link_color":[""],"header_contact_info_link_color_hover":[""],"header_button_custom_style":[""],"header_button_color":[""],"header_button_color_hover":[""],"header_button_bg":[""],"header_button_bg_hover":[""],"header_nav_menu_customize":[""],"header_nav_menu_link_color":[""],"header_nav_menu_link_color_hover":[""],"header_nav_menu_link_color_active":[""],"header_nav_menu_link_arrow_color":[""],"header_nav_menu_link_arrow_color_hover":[""],"header_nav_menu_level_1_bg":[""],"header_nav_menu_level_1_link_color":[""],"header_nav_menu_level_1_link_color_hover":[""],"header_nav_menu_level_1_link_bg_hover":[""],"header_nav_menu_level_1_link_arrow_color":[""],"header_nav_menu_level_1_link_arrow_color_hover":[""],"header_nav_menu_level_2_bg":[""],"header_nav_menu_level_2_link_color":[""],"header_nav_menu_level_2_link_color_hover":[""],"header_nav_menu_level_2_link_bg_hover":[""],"header_mega_menu_bg":[""],"header_mega_menu_title_color":[""],"header_mega_menu_title_color_hover":[""],"header_mega_menu_description_color":[""],"header_mega_menu_description_link_color":[""],"header_mega_menu_description_link_color_hover":[""],"header_mega_menu_color":[""],"header_mega_menu_color_hover":[""],"header_mega_menu_border_color":[""],"header_mega_menu_icons_color":[""],"header_nav_menu_customize_end":[""],"hfe_enabled_notice":[""],"disable_title_box":["default"],"hfe_disabled":[""],"enable_transparent":["default"],"title_box_title_bg_color":[""],"title_box_bg_custom_image":["default"],"title_box_bg_image":[""],"title_box_bg_position":["default"],"metabox_title_box_bg_position_x":[""],"metabox_title_box_bg_position_y":[""],"metabox_title_box_bg_attachment":["default"],"title_box_bg_size":["default"],"metabox_title_box_bg_size_slider":[""],"title_box_bg_repeat":["default"],"disable_title":["default"],"title_box_title_color":[""],"title_box_title_line_color":[""],"disable_breadcrumbs":["default"],"metabox_title_box_breadcrumbs_color":[""],"metabox_title_box_links_color":[""],"metabox_title_box_links_color_hover":[""],"content_bg_transparent":[""],"show_popup_single":[""],"popups_single":[""],"popups_single_event":[""],"popup_single_event_open_delay":[""],"popup_single_event_showing_in":[""],"popup_single_event_date_from":[""],"popup_single_event_date_to":[""],"popup_single_event_time_from":[""],"popup_single_event_time_to":[""],"popup_single_animation":[""],"popup_single_responsive":[""],"separator_footer_copyright_border_t":[""],"name":[""],"email":[""],"phone":[""],"company":[""],"memberId":[""],"testimonial_position":[""],"testimonial_company":[""],"testimonial_bg_img":[""],"testimonial_video_url":[""],"popups_width":[""],"popups_height":[""],"popups_image_bg":[""],"popups_color_bg":[""],"popups_border_radius":[""],"popups_template":[""],"rank_math_analytic_object_id":["10704"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2026\/05\/08131027\/Thyrocare-Technologies-Q4-FY26-Results.jpg","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/83818","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/26"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=83818"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/83818\/revisions"}],"predecessor-version":[{"id":83894,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/83818\/revisions\/83894"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/83892"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=83818"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=83818"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=83818"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}